News, features, and commentary about cancer-related issues
Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Three cycles could become the new standard for retinoblastoma, researchers say
-- News, features, and commentary about cancer-related issues